A peripartum cardiomyopathy case treated with bromocriptine

Authors : Şeyda GÜNAY, Osman Akın SERDAR, Dilek YEŞİLBURSA, Sümeyye GÜLLÜLÜ, Naile Bolca TOPAL

Pages : 117-119

Doi:10.46310/tjim.868729

View : 14 | Download : 6

Publication Date : 2021-03-07

Article Type : Other Papers

Abstract :Introduction: Peripartum cardiomyopathy is a rare disease that is difficult to diagnose and treat. Clinical findings are similar with heart failure. New treatments are needed in addition to the treatment of heart failure. Case Report: A 32-year-old woman presented with symptoms of heart failure 4 days after first delivery. Chest X-ray showed cardiomegaly. Serum BNP level was high. Transthoracic echocardiography insert ignore into journalissuearticles values(TTE); indicated dilated left atrium and left ventricle, severe mitral regurgitation and ventricular dysfunction. The global longitudinal strain was – 9.1%. Cardiac magnetic resonance imaging insert ignore into journalissuearticles values(MRI); revealed mid-myocardial staining detected in late phase images. Concomitant bromocriptine insert ignore into journalissuearticles values(2,5 mg po twice a day for 15 days and then 2,5 mg po once a day for 15 days); was used with standard heart failure therapy. At 6 months, TTE and cardiac MRI revealed normal biventricular function and size. Global longitudinal strain was –14%. Conclusion: Patients with peripartum cardiomyopathy may benefit from bromocriptine.
Keywords : peripartum, heart, failure, cardiomyoathy, bromocriptine